Submit

UTI Healthcare Fund - Regular Plan - Growth Option

(Erstwhile UTI Pharma & Healthcare Fund-Growth Option)
Fund House: UTI Mutual Fund
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 05-08-2005
Asset Class: Equity
Benchmark: S&P BSE Healthcare TRI
Expense Ratio: 2.48% As on (30-09-2022)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 725.41 Cr As on (31-10-2022)
Turn over: 35% | Exit Load: 1% for redemption within 30 days
NAV as on 30-11-2022

153.7047

0.17 (0.1075%)

CAGR Since Inception

13.11%

NIFTY 50 TRI 12.2%

PERFORMANCE

Returns Type:
of  : 
Start :  
End : 
Period:  
This Scheme
-
vs
NIFTY 50 TRI
-
Gold
-
PPF
-
Returns Type:
of  : 
  Period:  

Start :  
Period:  

RETURNS ANALYSIS

Submit
Submit
Submit

Fund Multiplier

Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)

Time Taken To Multiply
2x
4x
5x
10x
FUND
0 Years 4 Months
5 Years 2 Months
7 Years 9 Months
9 Years 8 Months
FD
11 years 10 Months
GOLD
8 years 9 Months
NIFTY
5 years 5 Months

 

Investment Objective

An open-end fund which exclusively invests in the equities of the pharma & healthcare sector companies. This fund is one of the growth sector fund s aiming to invest in companies engaged in business of manufacturing and marketing of bulk drug, formulations and health care products and service.

Current Asset Allocation (%)

Indicators

Volatility 15.99
Sharp Ratio 0.92
Alpha 1.44
Beta 0.93
Yield to Maturity -
Average Maturity -

PEER COMPARISON

Scheme Name Inception
Date		 1 Year
Return(%)		 2 Year
Return(%)		 3 Year
Return(%)		 5 Year
Return(%)		 10 Year
Return(%)
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 -5.98 7.3 21.73 12.22 12.65
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14-07-1999 1.93 11.39 24.31 12.53 14.58
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 -0.89 11.33 27.8 - -
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 08-11-2021 -1.38 - - - -
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 05-07-2018 -1.78 9.89 24.08 - -
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 -2.1 10.28 22.5 14.64 -
Nippon India Pharma Fund-Growth Plan-Growth Option 01-06-2004 -3.69 10.91 24.43 16.45 15.62
Mirae Asset Healthcare Fund -Regular Growth 10-07-2018 -4.84 11.76 26.5 - -
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 05-07-2019 -6.25 7.59 18.7 - -
IDBI Healthcare Fund - Regular Plan - Growth 22-02-2019 -6.73 4.99 18.1 - -

Scheme Characteristics

Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.

Riskometer

riskometer

PORTFOLIO

Market Cap Distribution

Small Cap

27.46%

Others

1.98%

Large Cap

45.18%

Mid Cap

25.39%

Scheme Documents

Fact Sheet for the month of October 2022

Monthly Portfolio Disclosure - October 2022

Tax Benefits of investing in this fund

Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#

Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.

Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **

# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund

Feedback
Notification